SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ginzburg, R.
Right arrow Articles by Barr, W. B.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Probable Labetalol-Induced Hepatotoxicity

Regina Ginzburg, PharmD

St. John's University College of Pharmacy & Allied Health Professions, Ambulatory Pharmacy Faculty, Beth Israel Residency in Urban Family Practice-Institute for Urban Family Health, 8000 Utopia Parkway, St. Albert's Hall Room 114, Queens, NY 11439, ginzburr{at}stjohns.edu

Resa Singleton, MD

Beth Israel Residency in Urban Family Practice-Institute for Urban Family Health, New York, New York

Wendy B. Barr, MD, MPH, MSCE

Beth Israel Residency in Urban Family Practice-Institute for Family Health, Jamaica, New York, New York

This article reports a case of probable hepatotoxicity induced by therapeutic doses of labetalol. A 34-year-old postpartum woman was started on labetalol during a preeclamptic episode in the hospital. During the patient's 4-week postpartum office visit, she reported having dark urine for the previous 2 weeks. A liver function test showed substantial enzyme elevation, which improved after discontinuation of labetalol therapy. Labetalol-induced hepatotoxicity, although uncommon, can occur. Published data report this occurrence only in middle-aged or older patients. This appears to be the first case report of postpartum labetalol-induced hepatotoxicity. Hepatotoxicity may occur as a result of labetalol therapy. More judicious monitoring in patients on labetalol therapy may be warranted to prevent serious outcomes.

Key Words: Labetalol • hepatotoxicity • postpartum.

Journal of Pharmacy Practice, Vol. 20, No. 3, 283-287 (2007)
DOI: 10.1177/0897190007306173
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement